How much funding has Toregem BioPharma raised?

Toregem BioPharma has raised $22.4M in total funding, most recently a Series A round.

When was Toregem BioPharma founded?

Toregem BioPharma was founded in 2020.

Where is Toregem BioPharma headquartered?

Toregem BioPharma is headquartered in Kyoto, Japan.

What industry is Toregem BioPharma in?

Toregem BioPharma operates in Biotech, Healthcare.

How many employees does Toregem BioPharma have?

Toregem BioPharma has 1-10 employees.

Toregem BioPharma

Q: Who are Toregem BioPharma's investors?

Toregem BioPharma's investors include Tohoku University Venture Partners, Astellas Venture Management, JIC Venture Growth Investments, Mitsubishi UFJ Financial.

For a society where people are not afraid of losing their teeth

Kyoto, Japan · Founded 2020 · $22.4M raised

Biotech

Healthcare

Headquarters: Kyoto
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: toregem.co.jp
Total Funding: $22.4M
Last Round: $2.6M Series AJun 2026
Rounds: 4

About

Toregem BioPharma develops regenerative treatments for tooth defects, enabling patients to regrow their own natural teeth. Founded from decades of Kyoto University research, the lead drug TRG035 blocks the USAG-1 protein that suppresses tooth growth. It targets congenital tooth agenesis and edentulous patients, advancing into Phase 2 clinical trials.

Summary

Toregem BioPharma is a Biotech company based in Kyoto, Japan, founded in 2020. It has raised $22.4M in total across 4 rounds, most recently a $2.6M Series A round in Jun 2026. Investors include Tohoku University Venture Partners, Astellas Venture Management and JIC Venture Growth Investments.